Rydex Europe Advantage Fund Class H (RYEUX)
| Fund Assets | 2.00M |
| Expense Ratio | 1.69% |
| Min. Investment | $2,500 |
| Turnover | 1,775.00% |
| Dividend (ttm) | 7.25 |
| Dividend Yield | 5.59% |
| Dividend Growth | -39.41% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 16, 2025 |
| Previous Close | 129.64 |
| YTD Return | 7.58% |
| 1-Year Return | 20.15% |
| 5-Year Return | 49.57% |
| 52-Week Low | 110.89 |
| 52-Week High | 134.80 |
| Beta (5Y) | n/a |
| Holdings | 56 |
| Inception Date | May 8, 2000 |
About RYEUX
Rydex Series Funds Europe 1.25X Strategy Fund is a leveraged mutual fund designed to offer investors exposure to European blue-chip equities with enhanced returns. The fund aims to provide investment results that correlate, before fees and expenses, to 125% of the daily performance of the STOXX Europe 50® Index, which represents fifty of the largest and most liquid companies across European developed markets. By employing a leveraged strategy, the fund seeks to amplify the index's daily movements, catering to investors with a higher risk tolerance who are looking to capitalize on the potential for greater short-term gains compared to traditional non-leveraged European equity funds. Notably, the fund invests primarily in the common stocks of companies included in its benchmark, with a focus on sectors such as finance, healthcare, industrials, and consumer goods, which are prominent within the STOXX Europe 50® Index. The fund is team-managed and is structured to allow tactical market positioning, making it a unique tool for those seeking to express directional views on European equity markets within their overall portfolio strategy.
Performance
RYEUX had a total return of 20.15% in the past year, including dividends. Since the fund's inception, the average annual return has been 1.30%.
Top 10 Holdings
50.05% of assets| Name | Symbol | Weight |
|---|---|---|
| J.P. MORGAN SECURITIES LLC TRI PARTY | n/a | 15.31% |
| MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED TRI PARTY | n/a | 13.91% |
| Guggenheim Ultra Short Duration Fund Institutional | GIYIX | 4.31% |
| Guggenheim Ultra Short Income ETF | GFSBX | 4.17% |
| ASML Holding N.V. | ASML | 3.31% |
| AstraZeneca PLC | AZN | 1.94% |
| Novartis AG | NVS | 1.85% |
| HSBC Holdings plc | HSBC | 1.79% |
| Roche Holding AG | RHHBY | 1.78% |
| Shell plc | SHEL | 1.68% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $7.25231 | Dec 16, 2025 |
| Dec 12, 2024 | $11.96903 | Dec 12, 2024 |
| Dec 12, 2023 | $0.74513 | Dec 12, 2023 |
| Dec 9, 2020 | $4.55411 | Dec 9, 2020 |
| Dec 10, 2019 | $0.44033 | Dec 10, 2019 |
| Dec 11, 2018 | $6.30238 | Dec 11, 2018 |